Drug intelligence / Profile preview

hydroxyethylstarch + albumin

Development stage
Unknown
Lead developer
B. Braun
Modality
Recombinant Proteins and Enzymes, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Intravenous
01

Overview

Hydroxyethylstarch + albumin is a combination of two colloid plasma volume expanders used for intravenous fluid replacement, particularly in settings of hypovolemia due to blood loss, trauma, or surgery. Hydroxyethyl starch (HES) is a synthetic polymer derived from amylopectin and acts as an artificial colloid to maintain or restore intravascular volume by increasing oncotic pressure and reducing capillary leakage. Albumin is a natural plasma protein purified from human blood that also increases oncotic pressure and helps retain fluid within the vasculature. Both agents are used as alternatives to crystalloids for volume resuscitation; however, their safety profiles differ. HES has been associated with increased risks of acute kidney injury and coagulopathy compared to albumin. Albumin may have protective effects on the vascular barrier through interaction with the endothelial glycocalyx. The combination may be considered in specific clinical scenarios such as plasma exchange or when both rapid volume expansion and maintenance of oncotic pressure are desired.

Beyond the preview

Go deeper on hydroxyethylstarch + albumin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hydroxyethylstarch + albumin.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call